R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Oncology Imaging Scientific Lead

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time$150.5k - $245.5k /yr

About the Job

Requirements

  • Experience implementing central efficacy assessment using tumor response criteria such as RECIST 1.1, PCWG3, Lugano, and IMWG in oncology clinical trials.
  • Leadership experience applying imaging as a quantitative endpoint in clinical and preclinical studies focused on oncology.
  • A doctorate degree in a relevant field and at least five years of industry and academic clinical oncology imaging experience.
  • Strong written and verbal communication and organizational skills.
  • Ability to champion imaging innovations and lead projects effectively.

Responsibilities

  • Work with imaging, therapeutic area, and development leads to formulate imaging biomarker strategies that inform and advance the clinical pipeline.
  • Lead, design, and implement multimodality imaging measures as endpoints for oncology therapeutic clinical studies.
  • Collaborate with clinical teams as the imaging subject matter expert to design and execute imaging strategies, including developing protocols, imaging manuals, imaging charters, and statistical analysis plans.
  • Work with Clinical Imaging Operations and imaging contract research organizations to ensure proper conduct and data integrity of study imaging components and endpoints.
  • Serve as Imaging Scientific Lead in clinical trials focused on qualification and utilization of novel imaging biomarkers.
  • Lead interactions with regulatory agencies and site ethics committees to obtain approval for clinical imaging biomarker development studies.
  • Design and implement novel PET, immuno-PET, and other novel imaging agents and biomarkers in clinical trials.
  • Oversee image analysis and interpretation of results, and work with colleagues to oversee development of study reports and publications as appropriate.
  • Design and implement innovative imaging translational strategies in collaboration with preclinical and clinical research teams and external partners.

Desired Qualifications

  • At least five years of imaging experience in oncology drug development and clinical PET tracer development in a pharmaceutical or biotechnology setting.
  • Experience applying imaging as a quantitative endpoint in clinical and preclinical studies.
  • Experience with regulatory agencies and inspections.
  • Direct experience with preclinical oncology imaging models using PET and immuno-PET imaging biomarkers.
  • Strong background in oncology, biology, and molecular imaging, and familiarity with precision medicine approaches.
  • Experience overseeing imaging contract research organizations and implementing quality control procedures.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs